Shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $129.00.
SLAB has been the subject of several recent research reports. StockNews.com lowered Silicon Laboratories from a "hold" rating to a "sell" rating in a report on Thursday, March 27th. Barclays decreased their target price on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a research note on Tuesday. Stifel Nicolaus dropped their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Benchmark restated a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Finally, KeyCorp upped their target price on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a report on Wednesday, January 22nd.
Read Our Latest Stock Analysis on SLAB
Insider Activity
In other Silicon Laboratories news, Director William G. Bock sold 1,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total value of $149,430.00. Following the sale, the director now owns 31,115 shares in the company, valued at $4,649,514.45. This trade represents a 3.11 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the company's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the transaction, the director now owns 400,567 shares in the company, valued at approximately $59,684,483. The trade was a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.
Institutional Investors Weigh In On Silicon Laboratories
Several large investors have recently added to or reduced their stakes in the stock. Coldstream Capital Management Inc. raised its stake in shares of Silicon Laboratories by 2.8% during the fourth quarter. Coldstream Capital Management Inc. now owns 2,473 shares of the semiconductor company's stock valued at $307,000 after acquiring an additional 68 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Silicon Laboratories by 44.5% during the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after buying an additional 69 shares in the last quarter. Pacer Advisors Inc. increased its stake in shares of Silicon Laboratories by 1.8% during the fourth quarter. Pacer Advisors Inc. now owns 4,839 shares of the semiconductor company's stock valued at $601,000 after buying an additional 87 shares during the period. Louisiana State Employees Retirement System raised its holdings in shares of Silicon Laboratories by 1.1% in the fourth quarter. Louisiana State Employees Retirement System now owns 9,000 shares of the semiconductor company's stock valued at $1,118,000 after acquiring an additional 100 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in Silicon Laboratories by 1.4% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 7,169 shares of the semiconductor company's stock worth $891,000 after acquiring an additional 102 shares during the period.
Silicon Laboratories Stock Performance
SLAB stock opened at $102.76 on Friday. The business's 50-day moving average is $116.65 and its two-hundred day moving average is $120.97. The company has a market cap of $3.34 billion, a price-to-earnings ratio of -17.30 and a beta of 1.33. Silicon Laboratories has a fifty-two week low of $82.82 and a fifty-two week high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company had revenue of $166.25 million for the quarter, compared to the consensus estimate of $166.09 million. During the same quarter last year, the firm posted ($1.19) earnings per share. The firm's revenue was up 91.4% compared to the same quarter last year. Equities analysts predict that Silicon Laboratories will post -0.97 earnings per share for the current year.
About Silicon Laboratories
(
Get Free ReportSilicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report